Team Pharmaceuticals Ltd. has announced the successful launch of Esotem MUPS, now available in two strengths: Esotem MUPS 20 mg and Esotem MUPS 40 mg. This latest addition strengthens the company’s gastroenterology portfolio and reflects its commitment to offering flexible and patient-focused treatment options.
Esotem MUPS is formulated using advanced Multiple Unit Pellet System (MUPS) technology, which enhances drug stability, ensures uniform drug release, and supports improved patient compliance. The availability of two strengths allows healthcare professionals to tailor therapy according to individual patient needs.
Manufactured at Team Pharmaceuticals’ state-of-the-art, GMP-compliant facility in Rajshahi, Esotem MUPS meets stringent quality and regulatory standards, ensuring consistent efficacy and safety. The product is designed to provide effective acid suppression and reliable therapeutic outcomes in the management of acid-related gastrointestinal disorders.
Management stated that the launch of Esotem MUPS 20 mg and 40 mg aligns with the company’s focus on innovation, quality manufacturing, and patient-centric care. With this introduction, Team Pharmaceuticals continues to expand its range of modern generic medicines to support healthcare professionals and patients alike.
